Speaking of that, although more from biotech executives rather than sell-side analysts, I get so annoyed every time I hear "leverage..." In conference calls or read it in press releases. Don't know why it bothers me so much, but it's a pet peeve of mine. It's like the only verb they feel they are allowed to use in that context. Sorry, end rant.
Market Data 
Markets 
AI
